| Home : July 2012 : July 30, 2012 News : Eisai and Arena Pharmaceuticals Complete Transfer of BELVIQ® (lorcaserin HCl) New Drug Application |
Eisai and Arena Pharmaceuticals Complete Transfer of BELVIQ® (lorcaserin HCl) New Drug Application |
July 30, 2012
WOODCLIFF LAKE, N.J., and SAN DIEGO, July 30, 2012 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that Arena has transferred the BELVIQ® (lorcaserin hydrochloride) New Drug Application (NDA) to Eisai. The transfer establishes...
http://www.prnewswire.com/news-releases/eisai-and-arena-pharmaceuticals-complete-transfer-of-belviq-lorcaserin-hcl-new-drug-application-164231086.html
|
|
|
 Other Stories |
|
|
|
|
|
|
|
|
|
|
|
